|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.7 USD | +0.07% |
|
-1.10% | -4.84% |
| May. 09 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
| May. 08 | Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing | MT |
Oct 21 (Reuters) - Abbott Laboratories posted a 28.3% rise in third-quarter profit on Wednesday, helped by strong sales of COVID-19 tests and strength in its nutrition and diabetes businesses.
The company's net earnings rose to $1.23 billion, or 69 cents per share, in the quarter ended Sept. 30, from $960 million, or 53 cents per share, a year earlier. (Reporting by Manojna Maddipatla and Trisha Roy in Bengaluru; Editing by Arun Koyyur)
| 1st Jan change | Capi. | |
|---|---|---|
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +24.51% | 32.3B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
ABBOTT LABORATORIES 